These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 18192918

  • 1. Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells.
    Guo K, Inaba M, Li M, An J, Cui W, Song C, Wang J, Cui Y, Sakaguchi Y, Tsuda M, Omae M, Ando Y, Li Q, Wang X, Feng W, Ikehara S.
    Transplantation; 2008 Jan 15; 85(1):93-101. PubMed ID: 18192918
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS, Li S, Zeevi A, Demetris AJ, Ildstad ST, Pham SM.
    Circulation; 1998 Nov 10; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [Abstract] [Full Text] [Related]

  • 3. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
    Kaneda H, Adachi Y, Saito Y, Ikebukuro K, Machida H, Suzuki Y, Minamino K, Zhang Y, Iwasaki M, Nakano K, Koike Y, Wang J, Imamura H, Ikehara S.
    J Heart Lung Transplant; 2005 Sep 10; 24(9):1415-23. PubMed ID: 16143265
    [Abstract] [Full Text] [Related]

  • 4. Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells.
    Esumi T, Inaba M, Ichioka N, Kushida T, Iida H, Ikehara S.
    Transplantation; 2003 Dec 15; 76(11):1543-8. PubMed ID: 14702521
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection.
    Nishida T, Hosaka N, Takaki T, Miyake T, Cui W, Inaba M, Kinoshita H, Matsuda T, Ikehara S.
    Bone Marrow Transplant; 2009 Jun 15; 43(11):829-37. PubMed ID: 19079314
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J, Ko S, Kanehiro H, Kanokogi H, Nakajima Y.
    J Surg Res; 2006 Jun 15; 133(2):61-8. PubMed ID: 16376943
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide.
    Okayama J, Ko S, Kanehiro H, Kanokogi H, Hisanaga M, Ohashi K, Sho M, Nagao M, Ikeda N, Kanamura T, Akashi S, Nakajima Y.
    J Surg Res; 2004 Jul 15; 120(1):102-10. PubMed ID: 15172196
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S, Salgar SK, Kurimoto Y, Yousem S, Pham SM.
    J Surg Res; 2008 May 15; 146(2):289-97. PubMed ID: 18314139
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The CD28 peptidemimic can induce mixed chimerism and prolong the survival of cardiac allografts.
    Chen J, He Q, Xu H, Su L, Zhang J, Xiong S.
    Transpl Immunol; 2004 Dec 15; 13(4):283-8. PubMed ID: 15589741
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.